Tolerance induction by monoclonal CD3 antibodies is dependent on indoleamine 2,3 dioxygenase (IDO)

Documenti analoghi

• Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges.
  di: Quan, J, et al.
  Pubblicazione: (2008)
• Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges
  di: Quan, J, et al.
  Pubblicazione: (2008)
• The role of indoleamine 2,3-dioxygenase (IDO) in the pathogenesis of non-alcoholic steatohepatitis (NASH) and atherosclerosis as comorbidities
  di: Arora, A, et al.
  Pubblicazione: (2021)
• Association of Indoleamine 2,3-dioxygenase (ido) activity with outcome after cardiac surgery in adult patients
  di: Stieger, A, et al.
  Pubblicazione: (2024)
• Rational design of indoleamine 2,3-dioxygenase inhibitors.
  di: Röhrig, U, et al.
  Pubblicazione: (2010)